Feb 9-11, 2023. T-CURX co-founder Prof. M. Hudecek is co-chairing the 5th European CAR-T congress of EHA in Rotterdam, The Netherlands

Prof. M. Hudecek is co-hosting and co-chairing the 5th European CAR-T cell congress of the European Hematology Association (EHA); Ulf Grawunder, CEO, and Jan Van den Brulle, Head of Preclinical Research at T-CURX will also attend the conference for partnering meetings and discussion with top-KOLs in the CAR-T cell field

The 5th European CAR-T cell congress organized by the European Hematology Association (EHA) will take place in Rotterdam from Feb 9-11, 2023 (see: https://ehaweb.org/meetings/cart5/). Prof. Michael Hudecek, MD, one of the co-founders of T-CURX, will co-chair the meeting and will give a keynote lecture at the conference about advances in CAR-T cell development for the treatment of acute myeloid leukemia (AML). Top key opinion leaders in the CAR-T cell field from Europe and the U.S. will attend the 5th European CAR-T cell conference of EHA and participate in panel discussion and keynote presentations. The meeting program can be downloaded via the following link: https://ehaweb.org/assets/Uploads/CART-meetings/CART2023/EBMT-EHA-5TH-CAR-T-CELL-MEETING_Programme.pdf. In addition, team members of T-CURX leaderhsip team, including Ulf Grawunder, PhD, CEO, as well as Jan Van den Brulle, PhD, Head of Preclincial Development of T-CURX will attend the meeting and will be available for partnering discussions and meetings on site. The conference will take place in the Postillion Hotel & Convention Center WTC Rotterdam, Beursplein 37, 3011 AA Rotterdam, The Netherlands.